Agilent Technologies
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Agilent Technologies (A) Business News
Track Agilent Technologies in real time with a live news feed covering Agilent Technologies stock news, official press releases, company announcements, and an archive of historical Agilent Technologies news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Agilent Technologies, Inc. $A Shares Bought by CCLA Investment Management
Agilent Technologies, Inc. $A Shares Bought by CCLA Investment Management
Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of “Moderate Buy” from Brokerages
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Has $1.70 Million Position in Agilent Technologies, Inc. $A
Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader
Why Is Agilent (A) Down 6.2% Since Last Earnings Report?
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma
Nordea Investment Management AB Sells 106,321 Shares of Agilent Technologies, Inc. $A
Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026
Danske Bank A S Takes $51.53 Million Position in Agilent Technologies, Inc. $A
Agilent Technologies, Inc. (A) Shareholder/Analyst Call Prepared Remarks Transcript
Agilent Technologies, Inc. $A Shares Bought by CCLA Investment Management
5:28 AM | Thursday | Apr 9, 2026
CCLA Investment Management grew its holdings in shares of Agilent Technologies, Inc. (NYSE: A) by 1.9% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,047,488 shares of the medical research company's stock after purchasing an additional 19,518 shares
Read full article
Agilent Technologies, Inc. $A Shares Bought by CCLA Investment Management
Defense WorldCCLA Investment Management grew its holdings in shares of Agilent Technologies, Inc. (NYSE: A) by 1.9% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,047,488 shares of the medical research company's stock after purchasing an additional 19,518 shares
Read full article
Agilent Technologies, Inc. $A Shares Bought by CCLA Investment Management
Defense WorldCCLA Investment Management grew its holdings in shares of Agilent Technologies, Inc. (NYSE: A) by 1.9% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,047,488 shares of the medical research company's stock after purchasing an additional 19,518 shares
Read full article
Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of “Moderate Buy” from Brokerages
Defense WorldAgilent Technologies, Inc. (NYSE: A - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the sixteen research firms that are presently covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to
Read full article
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Has $1.70 Million Position in Agilent Technologies, Inc. $A
Defense WorldEmpirical Financial Services LLC d.b.a. Empirical Wealth Management raised its holdings in Agilent Technologies, Inc. (NYSE: A) by 288.
9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,463 shares of the medical research company's stock after acquiring an additional 9,258
Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader
Business WireSANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation portfolio combining multimode microplate reading and high-content cell imaging in a single platform. Building on a decade of Cytation innovation and shaped by continuous customer feedback, the BioTek Cytation 9 helps laboratories move from samples to insights faster, supporting workflows from basic resea.
Read full article
Why Is Agilent (A) Down 6.2% Since Last Earnings Report?
Zacks Investment ResearchAgilent (A) reported earnings 30 days ago. What's next for the stock?
Read full article
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma
Business WireSANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to aid in identifying patients with esophageal or gastroesophageal junction (GEJ) carcinoma who may be eligible for treatment with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy.
PD-L1 IHC 22C3 pharmDx, Code SK006, is the only FDA-approved companion diagnostic indica.
Nordea Investment Management AB Sells 106,321 Shares of Agilent Technologies, Inc. $A
Defense WorldNordea Investment Management AB lessened its stake in Agilent Technologies, Inc. (NYSE: A) by 5.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,774,119 shares of the medical research company's stock after selling 106,321 shares during the period. Nordea Investment Management AB
Read full article
Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026
Business WireSANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it will feature its latest advances in precision oncology and digital pathology workflows at the 2026 United States and Canadian Academy of Pathology (USCAP) Annual Meeting, taking place March 21-26 in San Antonio, Texas. Agilent will highlight expanded biomarker testing capabilities, continued progress in digital pathology adoption, and the evolving role of the Dako Omnis family of instruments as a founda.
Read full article
Danske Bank A S Takes $51.53 Million Position in Agilent Technologies, Inc. $A
Defense WorldDanske Bank A S bought a new position in shares of Agilent Technologies, Inc. (NYSE: A) in the third quarter, according to the company in its most recent filing with the SEC. The firm bought 401,467 shares of the medical research company's stock, valued at approximately $51,528,000. Danske Bank A S owned approximately
Read full article
Agilent Technologies, Inc. (A) Shareholder/Analyst Call Prepared Remarks Transcript
Seeking AlphaAgilent Technologies, Inc. (A) Shareholder/Analyst Call Prepared Remarks Transcript
Read full article